|
|
La marihuana puede reducir el cáncer - CNNExpansión.com
2009-04-09 13:55:40
2009-04-09 13:55:40
 CNNExpansión.com | La marihuana puede reducir el cáncer CNNExpansión.com Sanofi-Aventis SA finalizó en noviembre un mayor desarrollo de ACOMPLIA, su medicina basada en cannabis, mientras que Pfizer Inc, Merck & Co Inc y la belga Solvay también descartaron recientemente productos similares por temores de salud. ... Un componente de la marihuana contra el cáncer |
Bristol-Myers Seeks to Stay Independent - Wall Street Journal
2009-04-09 13:11:02
2009-04-09 13:11:02
Bristol-Myers Seeks to Stay Independent Wall Street Journal Its biggest-selling drugs include anticlotting drug Plavix, hypertension medicine Avapro, cancer treatment Erbitux and the psychiatric drug ABILIFY. "There's no urgency to put a 'for sale' sign out there, but I'm also cognizant of shareholder value," ... Bristol-Myers Squibb: An Attractive Value Bristol, Biogen CEOs: We’re Not Rushing to Be Acquired FORMER BRISTOL-MYERS SQUIBB SENIOR EXECUTIVE PLEADS GUILTY FOR ... |
Pet Shop Boys reject PETA name change request - Hippy Shopper
2009-04-09 08:02:04
2009-04-09 08:02:04
Pet Shop Boys reject PETA name change request Hippy Shopper Much as they may protest at the ACCOLATE, the Pet Shop Boys have become a British institution. But PETA recently got in touch with the duo to ask them to do away with over 20 years of pop history, and change their name to something more animal-friendly ... |
Company and People Notes: BMS and Otsuka Extend Abilify Agreement ... - Pharmaceutical Technology Magazine
2009-04-09 06:36:20
2009-04-09 06:36:20
Company and People Notes: BMS and Otsuka Extend Abilify Agreement ... Pharmaceutical Technology Magazine Bristol-Myers Squibb (Princeton, NJ) and Otsuka Pharmaceutical (Tokyo) agreed to extend the US portion of the companies’ long-standing agreement for the development and commercialization of ABILIFY (aripiprazole) from the currently scheduled end date ... |
SANOFI-AVENTIS : acquisition du brésilien Medley pour 500 millions - TF1
2009-04-08 23:38:42
2009-04-08 23:38:42
 Zonebourse.com | SANOFI-AVENTIS : acquisition du brésilien Medley pour 500 millions TF1 Début juillet 2007, Sanofi a retiré le dossier d'homologation de l'ACOMPLIA aux Etats-Unis. Un comité de la FDA avait rejeté sa pilule anti-obésité Zimulti (molécule rimonabant). Les experts s'inquiètent des effets secondaires psychiatriques du produit ... PLUS: Sanofi-Aventis fait du shopping faute de mieux |
Marley's mentor gets music honour - BBC News
2009-04-08 15:26:02
2009-04-08 15:26:02
 BBC News | Marley's mentor gets music honour BBC News In the music magazine's other awards, former Island Records head of press Rob Partridge - who first suggested the label sign U2 - received a posthumous ACCOLATE, the Strat. In a video tribute to Partridge, who died last year, U2 singer Bono said the ... |
Study: Acid reflux drugs do nothing to stop asthma attacks - Columbus Dispatch
2009-04-08 14:11:59
2009-04-08 14:11:59
 Fresh News | Study: Acid reflux drugs do nothing to stop asthma attacks Columbus Dispatch It's fairly common for asthma patients to take a proton pump inhibitor, a class of drugs that also includes Prevacid, Prilosec, ACIPHEX, and Protonix, even if they don't suffer with heartburn or other symptoms of acid reflux. ... Nexium not useful against asthma -- report Common asthma treatment doubted |
2-in-1: Merck and Schering-Plough - Pharmafocus
2009-04-08 08:07:45
2009-04-08 08:07:45
2-in-1: Merck and Schering-Plough Pharmafocus The FDA recently rejected Merck's cholesterol-lowering drug Tredaptive/Cordaptive, and the company abandoned anti-obesity treatment taranabant after Sanofi-Aventis' similar drug ACOMPLIA was withdrawn from the market because of safety concerns. ... |
Mitsubishi and Affectis sign depression drug discovery deal - Hays Pharma
2009-04-07 10:13:24
2009-04-07 10:13:24
Mitsubishi and Affectis sign depression drug discovery deal Hays Pharma ... industry with strengths in central nervous system research" also reflects his company's competence. Earlier this week, Bristol-Myers Squibb and Otsuka announced that they have extended their collaboration to develop depression treatment ABILIFY. Japan Govt Searches Mitsubishi Tanabe Headquarters - Kyodo |
The nurse’s role in managing patients with bronchiectasis - Nursing Times
2009-04-07 09:23:35
2009-04-07 09:23:35
The nurse’s role in managing patients with bronchiectasis Nursing Times Evidence supporting the use of mucolytics such as carbocisteine and ACETYLCYSTEINE is poor, although some patients and clinicians believe they help expectoration (Rubin, 2007; Crockett, 2001). In patients with airway reversibility, short-acting ... |